Kidney Cancer Treatment Market By Treatment Type (Targeted Therapy {VEGF Inhibitors, mTOR Inhibitors}, Immunotherapy {PD-1/PD-L1 Inhibitors, Cytokine-based Drugs}, Chemotherapy, Radiation Therapy, Surgery, Ablation Therapy), By Cancer Type (Renal Cell Carcinoma, Transitional Cell Carcinoma, Wilms Tumor), By End-User (Hospitals, Specialty Clinics, Cancer Research Institute), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Dec 2024 | Report ID: MI1541 | 220 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Treatment Type

  • Targeted Therapy
    • VEGF Inhibitors
    • mTOR Inhibitors
  • Immunotherapy
    • PD-1/PD-L1 Inhibitors
    • Cytokine-based Drugs
  • Chemotherapy
  • Radiation Therapy
  • Surgery
  • Ablation Therapy

By Cancer Type

  • Renal Cell Carcinoma (RCC)
  • Transitional Cell Carcinoma (TCC)
  • Wilms Tumour

By End-User

  • Hospitals
  • Specialty Clinics
  • Cancer Research Institutes

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Bristol-Myers Squibb
  • Merck & Co.
  • Pfizer Inc.
  • Roche Holding AG
  • Novartis International AG
  • AstraZeneca PLC
  • Eli Lilly and Co.
  • Exelixis Inc.
  • Bayer AG
  • Ipsen Pharmaceuticals
  • AbbVie Inc.
  • Johnson & Johnson
  • Sanofi S.A.
  • Seagen Inc.
  • Stemline Therapeutics
  • Aravive Inc.
  • Viatris Inc.
  • Baxter International Inc.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing